BMY - Bristol-Myers Squibb wins EU nod for expanded Abecma indication
2024-01-26 08:09:58 ET
More on Bristol-Myers
- Bristol Myers Squibb: Might Be Approaching A Bottom In 2024
- Bristol-Myers Squibb: Big Dividend Yield, Unloved Big-Pharma Deal
- Bristol-Myers Squibb: I Went Looking For Value And Found A 4.63% Yield Also
- Bristol Myers sees $0.35 per share impact as Mirati acquisition completes
- CAR-T therapies to get boxed warning on blood cancer risk